Donate to support our work
Global Asthma Network Logo Global Asthma Network Global Asthma Network Logo

Clinical standards for asthma in September's IJTLD

New clinical standards for asthma have been published in the September issue of the The International Journal of Tuberculosis and Lung Disease. There was great participation from GAN collaborators in the Delphi process that underpinned the development of these standards, and many are included as authors. These first consensus-based clinical standards for asthma management in LMICs are intended to help clinicians provide the most effective care for people in resource-limited settings.

Download Standards

GAN Eczema Paper published with Editorial

The GAN Eczema Time Trends paper as been selected for the editorial in the March edition of Clinical and Experimental Allergy. These new global time trends provide important data for the scope and direction of eczema strategy.

Article | Editorial

GAN Asthma Management Paper published with Editorial and Podcast

The GAN Asthma Management paper has been published in the February edition of The Lancet Global Health. This editorial highlights once again the burden of asthma globally and the lack of progress in reducing the worldwide burden of asthma. Additionally the journal has interviewed the authors in a podcast discussing the findings of this new paper.

Asthma Management paper | Editorial | Podcast

Global Asthma Report 2022

The Global Asthma Report 2022 was launched on 10 November 2022 at the Union’s World Conference on Lung Health, by Innes Asher. The slides used in her presentation can be downloaded here. This state of the art Report is 102 pages (18 chapters) written by 97 authors from 31 countries around the world.

Download the report | view website

World Lung Day 2022: Lung Health for All

On World Lung Day, 25 September 2022, the Forum of International Respiratory Societies (FIRS) calls on governments worldwide to address stark global inequalities in respiratory health.

The COVID-19 pandemic may have subsided, but its impact highlights a global lung health crisis that has not gone away.

Read more

Latest GAN Newsletter available

The September 2022 GAN Newsletter is now available on the website. This is our 10 year anniversary Newsletter and includes contributions from our members towards this occasion. In addition, Included in the newsletter are articles on GAN Phase I update, New GAN publications, a FIRS Lung Health facts sheet for World Lung Day, Global Asthma Report update, GAN Centres update and GAN & GAR website usage view newsletter

GAN Asthma Papers published with Editorial

The GAN Asthma Child and adult worldmap papers have been published in the September edition of the European Respiratory Journal. This editorial highlights once again the burden of asthma globally and the importance of monitoring this disease.

Children Worldmap paper | Adult Worldmap paper | Editorial

GAN Rhinitis Paper selected for Editorial

The GAN Rhinitis Time Trends paper as been selected as Editors choice in the February edition of Paediatric Allergy and Immunology. These new global time trends provide important data for the scope and direction of rhinitis strategy.

Article | Editorial

Asthma Time Trends

First publication on asthma prevalence from the GAN Phase I published with open access in The Lancet. These new global asthma time trends provide important data for the scope and direction of asthma strategy. Read more

Article | Commentary | Press Release

Global Asthma Network Symposium 2024

Improving access to affordable inhaled medicines for all

22 January 2024, Auckland, New Zealand

This exciting all day event will include presentations and discussion of GAN Phase I papers and invited perspectives from asthma experts from New Zealand, the Global Initiative for Asthma (GINA), World Health Organization and others

This symposium builds on GAN’s state of the art Global Asthma Report 2022 -

Register Now

More Details | Download pdf flyer

Funding and development partners

The Global Asthma Network received major funding from The International Union Against Tuberculosis and Lung Disease (The Union) from 2012-2015. It is also generously supported by funding from the following organisations:

Global Asthma and Allergy Patient Platform
We thank the NIHR Global Health Research Unit on Lung Health and TB in Africa at LSTM - “IMPALA” for helping to make this work possible. In relation to IMPALA (project reference 16/136/35) specifically: IMPALA was funded by the National Institute for Health Research (NIHR) using UK aid from the UK Government to support global health research. The views expressed in this publication are those of the author(s) and not necessarily those of the NIHR or the UK Department of Health and Social Care.
OM Pharma
Asthma Australia
Woolcock Institute of Medical Research
Aix Marseille University
Center of Allergy & Immunology, Tbilisi
Riga Stradins University
New Zealand
The Asthma and Respiratory Foundation of New Zealand
Auckland Asthma Charitable Trust
Boehringer Ingelheim
University of Auckland
University of Murcia
Valencia University
Sultanate of Oman
The Oman Respiratory Society
United Kingdom
The London School of Hygiene and Tropical Medicine
St Georges University of London
UK Medical Research Council

Funders of GAN Phase I Centres

Individual centres involved in GAN Phase I data collection were funded by the following organisations:

Argentina, San Francisco
Funded by Dr Héctor Badellino
Brazil, Uruguaiana
Funded by Dr Marilyn Urrutia Pereira
Cameroon, Yaounde
Funded by Elvis Ndikum (95%) and from family, friends (5%)
Costa Rica
Partially funded by an unrestricted grant from Astra Zeneca for logistic purposes
India; Bikaner, Chandigarh, Jaipur, Kolkata, Kottayam, Lucknow, Mysuru, New Delhi, Pune
GAN Phase I was undertaken by Asthma Bhawan in India which was supported by Cipla foundation.
Iran, Karaj
Alborz University of medical Sciences
Kosovo, Gjakova
Municipality of Gjakova and the Directorate for Health and Education
Mexico, all centres
Astra Zeneca and COMPEDIA (Colegio Mexicano de Pediatras Especialistas en Inmunologia Clinica y Alergia) educational grants
Mexico, Puerto Vallarta
Centro Universitario de la Costa, Universidad de Guadalajara
New Zealand, Auckland
Auckland Asthma Charitable Trust
Nicaragua. Managua
Partially funded by an unrestricted grant from Astra Zeneca for logistic purposes
Nigeria, Ibadan
Funded by National Institute for Health Research (NIHR) (IMPALA, grant reference 16/136/35) using UK aid from the UK Government to support global health research
Poland, Katowice
Funded by the Medical University of Silesia
South Africa, Cape Town
Funded by the South African Medical Research Council and by the Allergy Society of South Africa for Heather Zar
Spain, Cartagena, Bilbao, Pamplona
Funded by Instituto de Salud Carlos III
Spain, Cantabria
Funded by Instituto de Investigación Sanitaria Valdecilla (IDIVAL) de Cantabria PRIMVAL 17/01 y 18/01,
Spain, Salamanca
Funded by Gerencia Regional de Salud de la Junta de Castilla y León Sociedad Española de Inmunología Clínica, Alergología y Asma Pediátrica,
Spain, A Coruña
Funded by María José Jove foundation.
Sri Lanka; Anuradhapura, Peradeniya
University of Peradeniya, Peradeniya, Sri Lanka
Syria; Damascus, Lattakia
Damascus: Syrian Private University
Lattakia: Lattakia Medical National Syndicate